Navigation Links
Serendipity points to new potential target and therapy for melanoma
Date:12/20/2012

A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.

"It's a double negative," says Yiqun Shellman, PhD, investigator at the CU Cancer Center, associate professor at the CU School of Medicine, and the study's co-senior author. "miR-26a works to stop the growth of cancer. You turn off this thing that should stop growth, and you have growth."

When Shellman, David Norris and colleagues reintroduced microRNA-26a to melanoma cell lines that lacked it, they saw a marked decrease in cancer cell survival. MicroRNA-26a killed melanoma cells while leaving healthy cells unharmed.

In fact, the discovery started back a couple steps. First the group compared microRNA expression in healthy cells to that of microRNA expression in melanoma cells. "We hoped the difference between microRNA expression in healthy and melanoma cells would show which ones were contributing to tumorgenesis," Shellman says.

The microRNA most consistently different between healthy and cancerous cells was 26a. The discovery of how it works and what exactly it does was serendipitous. "We started by testing the effect of microRNA-26a on known gene targets to see if it was effecting the expression of logical, cancer-causing pathways, but none of them seemed affected in melanoma," Shellman says. "We were working with the SODD gene in an unrelated project, and SODD has a putative but not high-scored binding site for miR-26a, and thought, why not test it? Sure enough, it turned out to be the target microRNA-26a downregulates this gene."

Shellman hopes this robust finding in cell cultures will help pave the way for future work with microRNA-26a as a therapeutic target in animal models and eventually a human trial.

"The first step is to further pinpoint the genetic signatures of the patients likely to benefit from microRNA-26a replacement therapy," Shellman says, noting that only some and not all melanoma cells were killed by miRNA replacement. "Maybe it's simply the downregulation of microRNA-26a itself, or maybe we can use SODD expression as the biomarker," Shellman says.

Once Shellman and colleagues discover the characteristics of a melanoma susceptible to microRNA-26a treatment, they hope funding will allow the lab to follow the promising therapy up the evolution from cells to humans.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Research pinpoints key gene for regenerating cells after heart attack
2. Protein injection points to muscular dystrophy treatment
3. University of Maryland School of Medicine, NIH study pinpoints brain areas role in learning
4. New study to examine ecological tipping points in hopes of preventing them
5. Remarkable enzyme points the way to reducing nitric acid use in industry
6. U OF A expert pinpoints nutrient behind fresh water algae blooms
7. Under the right conditions, peptide blocks HIV infection at multiple points along the way
8. Study points to causes of high dolphin deaths in Gulf of Mexico
9. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
10. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
11. Computer model pinpoints prime materials for efficient carbon capture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... (PRWEB) , ... June 21, 2017 , ... Building on ... more inspiring, and more informative on the very latest developments in radical life extension. ... fun of a festival, and the empowerment of personal development, making it the largest ...
(Date:6/22/2017)... ... ... The first human cell line HeLa, established in 1951, has entered cell ... human cell lines with HeLa cells were published. Until recently, cross-contamination and misidentification of ... associated with dramatic consequences for research. , In this educational webinar, which is ...
(Date:6/20/2017)... Iowa (PRWEB) , ... June 20, 2017 , ... ... chance to immediately determine the adulterants which pose the most likely threat to ... - 28 of this year. , IFT's annual food expo attracts over ...
(Date:6/19/2017)... Princeton, NJ (PRWEB) , ... June 19, 2017 ... ... responsible for overseeing all service activities supporting EDETEK’s products including training, implementation, support, ... industry experience to his new role. He has previously held leadership roles for ...
Breaking Biology Technology: